Display options
Cite
Wang Z, Wang B, Lou J, et al. Mutation in fiber of adenovirus serotype 5 gene therapy vector decreases liver tropism. Int J Clin Exp Med. 2014;7(12):4942-50
Wang, Z., Wang, B., Lou, J., Yan, J., Gao, L., Geng, R., & Yu, B. (2014). Mutation in fiber of adenovirus serotype 5 gene therapy vector decreases liver tropism. International journal of clinical and experimental medicine, 7(12), 4942-50.
Wang, Zhen, et al. "Mutation in fiber of adenovirus serotype 5 gene therapy vector decreases liver tropism." International journal of clinical and experimental medicine vol. 7,12 (2014): 4942-50.
Wang Z, Wang B, Lou J, Yan J, Gao L, Geng R, Yu B. Mutation in fiber of adenovirus serotype 5 gene therapy vector decreases liver tropism. Int J Clin Exp Med. 2014 Dec 15;7(12):4942-50. eCollection 2014. PMID: 25663991; PMCID: PMC4307438.
Copy Download .nbib Format: NLM
Share it on

Int J Clin Exp Med. 2014 Dec 15;7(12):4942-50. eCollection 2014.

Mutation in fiber of adenovirus serotype 5 gene therapy vector decreases liver tropism.

International journal of clinical and experimental medicine

Zhen Wang, Baoming Wang, Junfang Lou, Jingyi Yan, Lei Gao, Ranshen Geng, Bin Yu

Affiliations

  1. National Engineering Laboratory for AIDS Vaccine, School of Life Sciences, Jilin University Changchun 130012, China.
  2. Department of Neurology, The 208th hospital of PLA Changchun 130021, China.
  3. National Engineering Laboratory for AIDS Vaccine, School of Life Sciences, Jilin University Changchun 130012, China ; State Key Laboratory of Electroanalytical Chemistry, Changchun Institute of Applied Chemistry, Chinese Academy of Sciences Changchun 130022, China.

PMID: 25663991 PMCID: PMC4307438

Abstract

Recombinant adenovirus (Ad) vectors are widely used for both in vitro and in vivo gene transfer. However, intravenous administration of Ad vectors results mainly in hepatocyte transduction and subsequent hepatotoxicity. Coxsackie-adenovirus receptor (CAR) and αvβ integrins, which are functional receptors for the fiber and penton proteins, respectively, are the tropism determinants of Ad type 5 (Ad5). We previously developed a system for rapid construction of fiber-modified Ad5 vectors. We also constructed a fiber-modified Ad5 containing an Arg-Gly-Asp (RGD) motif in the HI-loop and showed that it could enhance anti-tumor effects in vitro and in vivo. Here, we constructed a novel Ad5 vector containing two amino acid mutations in the AB loop of the fiber-modified Ad5 fiber knob and showed that it could significantly reduce liver tropism and increase gene transfer in low-CAR or CAR-deficient cancer cells following intravascular delivery. However, anti-tumor effects of the fiber-mutated Ad5 expressing HSV-TK under control of the hTERT promoter was not found when compared with an unmodified Ad5 vector in cancer lines expressing different levels of CAR, likely due to the activity of the hTERT promoter being lower than that of the CMV promoter. Nevertheless, this study describes an enhanced Ad5 vector for intravascular gene delivery, and further modifications such as changes in the promoter may facilitate the development of this vector for cancer treatment.

Keywords: Adenovirus; coxsackie-adenovirus receptor; gene therapy; liver tropism

References

  1. Curr Opin Mol Ther. 2008 Oct;10(5):439-48 - PubMed
  2. Hum Gene Ther. 2005 Feb;16(2):248-61 - PubMed
  3. Viruses. 2010 Oct;2(10):2290-355 - PubMed
  4. Curr Gene Ther. 2011 Aug;11(4):241-58 - PubMed
  5. Cell Host Microbe. 2008 Mar 13;3(3):119-20 - PubMed
  6. Gene Ther. 2002 Jun;9(12 ):769-76 - PubMed
  7. J Med Virol. 2012 Sep;84(9):1408-14 - PubMed
  8. Expert Opin Drug Deliv. 2014 Mar;11(3):379-92 - PubMed
  9. Science. 1997 Feb 28;275(5304):1320-3 - PubMed
  10. Int J Clin Exp Pathol. 2014 May 15;7(6):2850-60 - PubMed
  11. Proc Natl Acad Sci U S A. 2013 Mar 5;110(10):E869-77 - PubMed
  12. Gene Ther. 2001 Jan;8(1):49-57 - PubMed
  13. J Virol. 1998 Dec;72 (12 ):9706-13 - PubMed
  14. Gene Ther. 2001 Sep;8(17):1347-53 - PubMed
  15. Clin Cancer Res. 2002 Jan;8(1):275-80 - PubMed
  16. J Virol. 2001 Dec;75(23):11284-91 - PubMed
  17. J Virol. 2000 Mar;74(6):2804-13 - PubMed
  18. Oncol Rep. 2011 Jul;26(1):255-64 - PubMed
  19. Cell. 1993 Apr 23;73(2):309-19 - PubMed

Publication Types